Review



human dll 1  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Sino Biological human dll 1
    Human Dll 1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/Human+DLL4%2FDelta-like+4+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-GFPSpark+tag/pm40154481-794-23-25
    Average 94 stars, based on 1 article reviews
    human dll 1 - by Bioz Stars, 2026-10
    94/100 stars

    Images



    Similar Products

    94
    Sino Biological human dll 1
    Human Dll 1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/Human+DLL4%2FDelta-like+4+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-GFPSpark+tag/pm40154481-794-23-25
    Average 94 stars, based on 1 article reviews
    human dll 1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Sino Biological hg19075 ut human dll
    Hg19075 Ut Human Dll, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/Human+JAG2+Gene+ORF+cDNA+clone+expression+plasmid/pm40154481-720-72-75
    Average 93 stars, based on 1 article reviews
    hg19075 ut human dll - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    R&D Systems dll 1
    Dll 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/Recombinant+Human+DLL1+His-tag+Protein%2C+CF/pm37451260-294-45-46
    Average 90 stars, based on 1 article reviews
    dll 1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    92
    Sino Biological dll 1
    ( A and C ) Histograms showing binding of PAC-1 ( A ) and anti-P-selectin antibody ( C ) to platelets pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) or <t>DLL-1</t> (15 µg/ml) for 10 min, or with thrombin (Thr, 1 U/ml) for 5 min at 37 °C as indicated. ( B and D ) Ccorresponding mean fluorescence intensities of PAC-1 (n=12) and anti-P-selectin antibody (n=9) binding to platelets, respectively. ( E ) Bar diagram representing ATP secretion from platelet dense granules pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 for 10 min (n=4). ( F ) Fura-2-loaded platelets were pre-treated for 5 min either with calcium (1 mM) or EGTA (1 mM) followed by incubation with DLL-4 (15 µg/ml) for 15 min and intracellular Ca 2+ was measured. ( G ) Corresponding bar diagram representing mean concentration of intracellular Ca 2+ over 300 sec of measurement (n=5). ( H ) Platelets were pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 (15 µg/ml) for 10 min at RT. PEVs were isolated and analyzed with Nanoparticle Tracking Analyzer (n=8). ( I ) Immunoblot showing profile of tyrosine phosphorylated proteins in platelets pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) for 10 min at RT or DLL-1 (15 µg/ml) for 10 min at RT or with thrombin (1 U/ml) for 5 min at 37 °C as indicated (n=4). Arrows indicate position of peptides whose intensity increased in presence of DLL-4. ( J and L ) Immunoblots showing expression of p-PI3K and pAKT in DLL-4 (15 µg/ml for 10 min)-treated platelets in absence or presence of either DAPT (10 µM) or vehicle. ( K and M ) Corresponding densitometric analyses normalised with PI3K (n=3) and AKT (n=7), respectively. Data are presented as mean ± SEM of at least three different experiments. Results were analyzed by RM one-way ANOVA with either Dunnett’s multiple comparisons test ( E , H , K and M ) or Sidak’s multiple comparisons test ( B , D and G ). Figure 3—source data 1. Excel sheet shows numerical data of . Figure 3—source data 2. Unedited and labelled blots of . Figure 3—source data 3. Unedited and unlabelled blots of .
    Dll 1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/Human+DLL1+%2F+Delta-1+Protein/pmc09629830-18-4-6
    Average 92 stars, based on 1 article reviews
    dll 1 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    90
    Kaneka Corp anti-phospho-n2bus-titin (s4062 in human titin) against dlls(po3h2)keslls (1:100)
    ( A and C ) Histograms showing binding of PAC-1 ( A ) and anti-P-selectin antibody ( C ) to platelets pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) or <t>DLL-1</t> (15 µg/ml) for 10 min, or with thrombin (Thr, 1 U/ml) for 5 min at 37 °C as indicated. ( B and D ) Ccorresponding mean fluorescence intensities of PAC-1 (n=12) and anti-P-selectin antibody (n=9) binding to platelets, respectively. ( E ) Bar diagram representing ATP secretion from platelet dense granules pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 for 10 min (n=4). ( F ) Fura-2-loaded platelets were pre-treated for 5 min either with calcium (1 mM) or EGTA (1 mM) followed by incubation with DLL-4 (15 µg/ml) for 15 min and intracellular Ca 2+ was measured. ( G ) Corresponding bar diagram representing mean concentration of intracellular Ca 2+ over 300 sec of measurement (n=5). ( H ) Platelets were pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 (15 µg/ml) for 10 min at RT. PEVs were isolated and analyzed with Nanoparticle Tracking Analyzer (n=8). ( I ) Immunoblot showing profile of tyrosine phosphorylated proteins in platelets pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) for 10 min at RT or DLL-1 (15 µg/ml) for 10 min at RT or with thrombin (1 U/ml) for 5 min at 37 °C as indicated (n=4). Arrows indicate position of peptides whose intensity increased in presence of DLL-4. ( J and L ) Immunoblots showing expression of p-PI3K and pAKT in DLL-4 (15 µg/ml for 10 min)-treated platelets in absence or presence of either DAPT (10 µM) or vehicle. ( K and M ) Corresponding densitometric analyses normalised with PI3K (n=3) and AKT (n=7), respectively. Data are presented as mean ± SEM of at least three different experiments. Results were analyzed by RM one-way ANOVA with either Dunnett’s multiple comparisons test ( E , H , K and M ) or Sidak’s multiple comparisons test ( B , D and G ). Figure 3—source data 1. Excel sheet shows numerical data of . Figure 3—source data 2. Unedited and labelled blots of . Figure 3—source data 3. Unedited and unlabelled blots of .
    Anti Phospho N2bus Titin (S4062 In Human Titin) Against Dlls(po3h2)keslls (1:100), supplied by Kaneka Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/anti+titin+antibodies/pm29727215-118-65-31
    Average 90 stars, based on 1 article reviews
    anti-phospho-n2bus-titin (s4062 in human titin) against dlls(po3h2)keslls (1:100) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal igg against human dll-1 (h-265
    (A) Flow cytometric analysis of NGFR expression in control vector- (C), human Jagged-1 (J1)- and human <t>Dll-1</t> (D1)-transfected HESS-5 cells, and the sorting gate (R2) for NGFR + transfected cells. (B) Western blot analysis of hJagged-1 and hDll-1 proteins in HESS-5 cells. Actin was used as an internal control. (C) Notch1 and Notch2 reporter cell lines transfected with RBP-Jk-luc were co-cultured with HESS-5 stromal cells. Luciferase activity (relative light units) was normalized to the activity of Renilla luciferase. Data are expressed as means ± standard deviation (SD) (n = 3). *P < 0.01 between the indicated values.
    Rabbit Polyclonal Igg Against Human Dll 1 (H 265, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/dll1+antibody/pmc05112804-61-34-41
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal igg against human dll-1 (h-265 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    R&D Systems human delta like ligand dll 4
    (A) Flow cytometric analysis of NGFR expression in control vector- (C), human Jagged-1 (J1)- and human <t>Dll-1</t> (D1)-transfected HESS-5 cells, and the sorting gate (R2) for NGFR + transfected cells. (B) Western blot analysis of hJagged-1 and hDll-1 proteins in HESS-5 cells. Actin was used as an internal control. (C) Notch1 and Notch2 reporter cell lines transfected with RBP-Jk-luc were co-cultured with HESS-5 stromal cells. Luciferase activity (relative light units) was normalized to the activity of Renilla luciferase. Data are expressed as means ± standard deviation (SD) (n = 3). *P < 0.01 between the indicated values.
    Human Delta Like Ligand Dll 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+dll+1/Recombinant+Human+CCL15%2FMIP-1+delta+Protein/pm25837583-101-11-17
    Average 86 stars, based on 1 article reviews
    human delta like ligand dll 4 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A and C ) Histograms showing binding of PAC-1 ( A ) and anti-P-selectin antibody ( C ) to platelets pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) or DLL-1 (15 µg/ml) for 10 min, or with thrombin (Thr, 1 U/ml) for 5 min at 37 °C as indicated. ( B and D ) Ccorresponding mean fluorescence intensities of PAC-1 (n=12) and anti-P-selectin antibody (n=9) binding to platelets, respectively. ( E ) Bar diagram representing ATP secretion from platelet dense granules pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 for 10 min (n=4). ( F ) Fura-2-loaded platelets were pre-treated for 5 min either with calcium (1 mM) or EGTA (1 mM) followed by incubation with DLL-4 (15 µg/ml) for 15 min and intracellular Ca 2+ was measured. ( G ) Corresponding bar diagram representing mean concentration of intracellular Ca 2+ over 300 sec of measurement (n=5). ( H ) Platelets were pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 (15 µg/ml) for 10 min at RT. PEVs were isolated and analyzed with Nanoparticle Tracking Analyzer (n=8). ( I ) Immunoblot showing profile of tyrosine phosphorylated proteins in platelets pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) for 10 min at RT or DLL-1 (15 µg/ml) for 10 min at RT or with thrombin (1 U/ml) for 5 min at 37 °C as indicated (n=4). Arrows indicate position of peptides whose intensity increased in presence of DLL-4. ( J and L ) Immunoblots showing expression of p-PI3K and pAKT in DLL-4 (15 µg/ml for 10 min)-treated platelets in absence or presence of either DAPT (10 µM) or vehicle. ( K and M ) Corresponding densitometric analyses normalised with PI3K (n=3) and AKT (n=7), respectively. Data are presented as mean ± SEM of at least three different experiments. Results were analyzed by RM one-way ANOVA with either Dunnett’s multiple comparisons test ( E , H , K and M ) or Sidak’s multiple comparisons test ( B , D and G ). Figure 3—source data 1. Excel sheet shows numerical data of . Figure 3—source data 2. Unedited and labelled blots of . Figure 3—source data 3. Unedited and unlabelled blots of .

    Journal: eLife

    Article Title: Notch signaling functions in noncanonical juxtacrine manner in platelets to amplify thrombogenicity

    doi: 10.7554/eLife.79590

    Figure Lengend Snippet: ( A and C ) Histograms showing binding of PAC-1 ( A ) and anti-P-selectin antibody ( C ) to platelets pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) or DLL-1 (15 µg/ml) for 10 min, or with thrombin (Thr, 1 U/ml) for 5 min at 37 °C as indicated. ( B and D ) Ccorresponding mean fluorescence intensities of PAC-1 (n=12) and anti-P-selectin antibody (n=9) binding to platelets, respectively. ( E ) Bar diagram representing ATP secretion from platelet dense granules pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 for 10 min (n=4). ( F ) Fura-2-loaded platelets were pre-treated for 5 min either with calcium (1 mM) or EGTA (1 mM) followed by incubation with DLL-4 (15 µg/ml) for 15 min and intracellular Ca 2+ was measured. ( G ) Corresponding bar diagram representing mean concentration of intracellular Ca 2+ over 300 sec of measurement (n=5). ( H ) Platelets were pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with DLL-4 (15 µg/ml) for 10 min at RT. PEVs were isolated and analyzed with Nanoparticle Tracking Analyzer (n=8). ( I ) Immunoblot showing profile of tyrosine phosphorylated proteins in platelets pre-treated with either DAPT (10 µM) or DBZ (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) for 10 min at RT or DLL-1 (15 µg/ml) for 10 min at RT or with thrombin (1 U/ml) for 5 min at 37 °C as indicated (n=4). Arrows indicate position of peptides whose intensity increased in presence of DLL-4. ( J and L ) Immunoblots showing expression of p-PI3K and pAKT in DLL-4 (15 µg/ml for 10 min)-treated platelets in absence or presence of either DAPT (10 µM) or vehicle. ( K and M ) Corresponding densitometric analyses normalised with PI3K (n=3) and AKT (n=7), respectively. Data are presented as mean ± SEM of at least three different experiments. Results were analyzed by RM one-way ANOVA with either Dunnett’s multiple comparisons test ( E , H , K and M ) or Sidak’s multiple comparisons test ( B , D and G ). Figure 3—source data 1. Excel sheet shows numerical data of . Figure 3—source data 2. Unedited and labelled blots of . Figure 3—source data 3. Unedited and unlabelled blots of .

    Article Snippet: Peptide, recombinant protein , DLL-1 , Sino Biological , 11635-H08H , 15 µg/ml.

    Techniques: Binding Assay, Incubation, Fluorescence, Concentration Assay, Isolation, Western Blot, Expressing

    ( A ) Histogram showing binding of Alexa Fluor 488-labelled fibrinogen (10 µg/ml) to platelets pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) or DLL-1 (15 µg/ml) for 10 min, or with thrombin (1 U/ml) for 5 min at 37 °C as indicated. ( B ) Corresponding mean fluorescence intensity of fibrinogen binding to platelets presented as mean ± SEM. Data are representative of nine (n=9) different experiments-and analysed by RM one-way ANOVA with Sidak’s multiple comparisons test. Figure 3—figure supplement 1—source data 1. Excel sheet shows numerical data of .

    Journal: eLife

    Article Title: Notch signaling functions in noncanonical juxtacrine manner in platelets to amplify thrombogenicity

    doi: 10.7554/eLife.79590

    Figure Lengend Snippet: ( A ) Histogram showing binding of Alexa Fluor 488-labelled fibrinogen (10 µg/ml) to platelets pre-incubated with either DAPT (10 µM) or vehicle for 10 min at RT followed by treatment with either DLL-4 (15 µg/ml) or DLL-1 (15 µg/ml) for 10 min, or with thrombin (1 U/ml) for 5 min at 37 °C as indicated. ( B ) Corresponding mean fluorescence intensity of fibrinogen binding to platelets presented as mean ± SEM. Data are representative of nine (n=9) different experiments-and analysed by RM one-way ANOVA with Sidak’s multiple comparisons test. Figure 3—figure supplement 1—source data 1. Excel sheet shows numerical data of .

    Article Snippet: Peptide, recombinant protein , DLL-1 , Sino Biological , 11635-H08H , 15 µg/ml.

    Techniques: Binding Assay, Incubation, Fluorescence

    (A) Flow cytometric analysis of NGFR expression in control vector- (C), human Jagged-1 (J1)- and human Dll-1 (D1)-transfected HESS-5 cells, and the sorting gate (R2) for NGFR + transfected cells. (B) Western blot analysis of hJagged-1 and hDll-1 proteins in HESS-5 cells. Actin was used as an internal control. (C) Notch1 and Notch2 reporter cell lines transfected with RBP-Jk-luc were co-cultured with HESS-5 stromal cells. Luciferase activity (relative light units) was normalized to the activity of Renilla luciferase. Data are expressed as means ± standard deviation (SD) (n = 3). *P < 0.01 between the indicated values.

    Journal: PLoS ONE

    Article Title: Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133 + Human Cord Blood Cells for Postnatal Vasculogenesis

    doi: 10.1371/journal.pone.0166660

    Figure Lengend Snippet: (A) Flow cytometric analysis of NGFR expression in control vector- (C), human Jagged-1 (J1)- and human Dll-1 (D1)-transfected HESS-5 cells, and the sorting gate (R2) for NGFR + transfected cells. (B) Western blot analysis of hJagged-1 and hDll-1 proteins in HESS-5 cells. Actin was used as an internal control. (C) Notch1 and Notch2 reporter cell lines transfected with RBP-Jk-luc were co-cultured with HESS-5 stromal cells. Luciferase activity (relative light units) was normalized to the activity of Renilla luciferase. Data are expressed as means ± standard deviation (SD) (n = 3). *P < 0.01 between the indicated values.

    Article Snippet: The proteins were transferred to nitrocellulose membranes (Hybond-ECL; Amersham Pharmacia Biotech, Piscataway, NJ), and incubated overnight at 4°C with primary antibodies: goat polyclonal IgG against human Jagged-1 (C-20) (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal IgG against human Dll-1 (H-265) (Santa Cruz Biotechnology), or rabbit polyclonal IgG against actin (Sigma).

    Techniques: Expressing, Plasmid Preparation, Transfection, Western Blot, Cell Culture, Luciferase, Activity Assay, Standard Deviation